Arix Bioscience Bilan de santé
Santé financière contrôle des critères 6/6
Arix Bioscience has a total shareholder equity of £239.1M and total debt of £0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are £240.5M and £1.4M respectively. Arix Bioscience's EBIT is £8.2M making its interest coverage ratio -2.4. It has cash and short-term investments of £101.0M.
Informations clés
0%
Ratio d'endettement
UK£0
Dette
| Ratio de couverture des intérêts | -2.4x |
| Argent liquide | UK£100.99m |
| Fonds propres | UK£239.12m |
| Total du passif | UK£1.41m |
| Total des actifs | UK£240.53m |
Mises à jour récentes de la santé financière
Pas de mise à jour
Analyse de la situation financière
Passif à court terme: ARIX's short term assets (£103.4M) exceed its short term liabilities (£1.4M).
Passif à long terme: ARIX has no long term liabilities.
Historique et analyse du ratio d'endettement
Niveau d'endettement: ARIX is debt free.
Réduire la dette: ARIX has not had any debt for past 5 years.
Couverture de la dette: ARIX has no debt, therefore it does not need to be covered by operating cash flow.
Couverture des intérêts: ARIX has no debt, therefore coverage of interest payments is not a concern.